Sirona Biochem (CVE:SBM) Trading Down 18.8% – Here’s What Happened

Shares of Sirona Biochem Corp. (CVE:SBM) were down 18.8% during mid-day trading on Monday . The company traded as low as C$0.07 and last traded at C$0.07. Approximately 112,944 shares were traded during mid-day trading, an increase of 44% from the average daily volume of 78,445 shares. The stock had previously closed at C$0.08.

Sirona Biochem Trading Down 18.8 %

The firm has a 50-day moving average of C$0.07 and a 200 day moving average of C$0.06. The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21. The stock has a market capitalization of C$16.69 million, a price-to-earnings ratio of -6.50 and a beta of -0.03.

Sirona Biochem Company Profile

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.